PKBO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PKBO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Peak Bio's change in working capital for the quarter that ended in Jun. 2024 was $0.65 Mil.
Peak Bio's change in working capital for the fiscal year that ended in Dec. 2023 was $3.66 Mil.
It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).
The historical data trend for Peak Bio's Change In Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peak Bio Annual Data | |||||||
Trend | Dec21 | Dec22 | Dec23 | ||||
Change In Working Capital | 0.09 | 2.37 | 3.66 |
Peak Bio Quarterly Data | ||||||||||||
Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Change In Working Capital | Get a 7-Day Free Trial | 1.31 | 1.32 | -0.56 | 0.89 | 0.65 |
Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.30 Mil.
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.
Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.
Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC
Consolidated Statements of Cash Flows | Fiscal Years Ended | January 31, | (Amounts in millions) |
Cash flows from operating activities: | 2014 | 2013 | 2012 |
Changes in certain assets and liabilities, net of effects of acquisitions: | |||
Receivables, net | (566) | (614) | (796) |
Inventories | (1,667) | (2,759) | (3,727) |
Accounts payable | 531 | 1,061 | 2,687 |
Accrued liabilities | 103 | 271 | (935) |
Accrued income taxes | (1,224) | 981 | 994 |
For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Peak Bio's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.
Hoyoung Huh | director | C/O NEKTAR THERAPEUTICS, 201 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Michael R. Friedman | director | 245 E. 58TH STREET, APT #15B, NEW YORK NY 10022 |
Peter David Mccabe | officer: General Counsel | 584 CASTRO STREET, #882, SAN FRANCISCO CA 94114 |
Sbi Kis 2016-1 Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO GANGNAM, SEOUL M5 00000 |
2014 Kif-sbi It Investment Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
2019 Sbi Job Creation Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Sbi Investment Korea Co., Ltd. | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Sbi Healthcare Fund I | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Sbi Cross-border Advantage Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Bio Fund 1 Ikbc-sbi | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Gateway Fund 1 Global | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Nevan C Elam | director | C/O NEKTAR THERAPEUTICS, 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Satyajit Kumar Mitra | officer: See Remarks | 3350 W BAYSHORE ROAD, SUITE 100, PALO ALTO CA 94303 |
Stephen J Lamond | director, officer: See Remarks | 3350 W BAYSHORE ROAD, SUITE 100, PALO ALTO CA 94303 |
David I. Rosenberg | director | C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019 |
From GuruFocus
By GuruFocus Research • 09-14-2023
By Marketwired • 08-31-2023
By PRNewswire • 03-05-2024
By Business Wire Business Wire • 11-04-2022
By Marketwired • 08-31-2023
By Marketwired • 09-19-2023
By Marketwired • 05-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.